A23K50/30

Use of <i>Coriobacteriia </i>to promote gut health

The present invention relates to a use of a microorganism of the class Coriobacteriia for promoting gut health of a healthy subject. Also provided is a method for the production of chenodeoxycholic acid (CDCA) and a method for the production of lithocholic acid (LCA).

Use of <i>Coriobacteriia </i>to promote gut health

The present invention relates to a use of a microorganism of the class Coriobacteriia for promoting gut health of a healthy subject. Also provided is a method for the production of chenodeoxycholic acid (CDCA) and a method for the production of lithocholic acid (LCA).

Methods of microbial oil extraction and separation

Lipids can be extracted from a microbial biomass that constitutes at least 20% lipids by weight and has a moisture content of less than 4% by weight by applying pressure to the biomass so as to release lipids therefrom, thereby leaving a biomass of reduced lipid content; and collecting the lipids.

Methods of microbial oil extraction and separation

Lipids can be extracted from a microbial biomass that constitutes at least 20% lipids by weight and has a moisture content of less than 4% by weight by applying pressure to the biomass so as to release lipids therefrom, thereby leaving a biomass of reduced lipid content; and collecting the lipids.

ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE
20220409644 · 2022-12-29 ·

Provided herein are oligosaccharide compositions for administration to animals suitable for improving animal health, including, for example, to treat diseases or disorders or to enhance animal growth.

ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE
20220409644 · 2022-12-29 ·

Provided herein are oligosaccharide compositions for administration to animals suitable for improving animal health, including, for example, to treat diseases or disorders or to enhance animal growth.

LACTOSE-CONTAINING PRODUCT IN POWDER FORM AND PRODUCTION PROCESS THEREOF
20220408744 · 2022-12-29 · ·

A product in powder form having a dry matter content of at least 90% by weight on its total weight and containing lactose in a quantity of at least 85% by weight on its total weight, as well as having a high bulk density; moreover a process for the production of this product in powder form is disclosed, comprising the steps of vacuum-concentrating a lactose-containing liquid, mixing the so-concentrated liquid with a lactose-containing powder and with a high dry matter content and, finally, drying the so-obtained powdered mixture.

NEAT REACTION PRODUCT OF CALCIUM AND VOLATILE FATTY ACIDS AS NUTRITIONAL SUPPLEMENT FOR LIVESTOCK AND POULTRY
20220400705 · 2022-12-22 ·

A process and composition for animal feed supplements without substantial foul odor problems prepared by reacting neat, a calcium metal source selected from the group consisting of calcium oxide and calcium hydroxide with a low molecular weight volatile fatty acid selected from the group consisting of butyric acid, isobutyric acid, 2 methyl butyric acid, valeric acid and isovaleric acid. Under controlled reaction conditions (neat) and a controlled weight ratio of the two reactants a product that is substantially odor free and useful as an animal feed supplement results.

NEAT REACTION PRODUCT OF CALCIUM AND VOLATILE FATTY ACIDS AS NUTRITIONAL SUPPLEMENT FOR LIVESTOCK AND POULTRY
20220400705 · 2022-12-22 ·

A process and composition for animal feed supplements without substantial foul odor problems prepared by reacting neat, a calcium metal source selected from the group consisting of calcium oxide and calcium hydroxide with a low molecular weight volatile fatty acid selected from the group consisting of butyric acid, isobutyric acid, 2 methyl butyric acid, valeric acid and isovaleric acid. Under controlled reaction conditions (neat) and a controlled weight ratio of the two reactants a product that is substantially odor free and useful as an animal feed supplement results.

<i>Clostridium perfringens </i>bacteriophage Clo-PEP-2 and use for inhibiting <i>Clostridium perfringens </i>proliferation of same

The present invention relates to Siphoviridae bacteriophage Clo-PEP-2 (accession number KCTC 13185BP), separated from nature, which is capable of killing Clostridium perfringens and has a genome expressed by sequence number 1 and a method for preventing or treating diseases, induced by Clostridium perfringens, by means of a composition comprising the Siphoviridae bacteriophage Clo-PEP-2 as an active ingredient.